Evidence for glucokinase translocation by glucose in rat hepatocytes. 1994

Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
Department of Clinical Biochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.

By an immunohistochemical technique, we examined changes in the subcellular distribution of rat liver glucokinase in response to external stimuli. Glucokinase immunoreactivity was found predominantly in the nucleus of hepatocytes. In situ perfusion of the liver with 20 mM glucose for 10 min caused a marked decrease in nuclear immunoreactivity and an increase in cytoplasmic immunoreactivity. Insulin (10 nmol/l) potentiated this glucose effect. However, no change took place when 5 mM glucose was perfused. These results indicate that glucokinase is translocated from the nucleus to the cytoplasm in response to a high concentration of glucose.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
March 2000, The Biochemical journal,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
December 1993, The Biochemical journal,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
February 1997, Biochemical Society transactions,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
February 1994, The Biochemical journal,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
October 2008, Journal of biomolecular screening,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
December 1999, FEBS letters,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
January 1998, Advances in enzyme regulation,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
August 1978, The Biochemical journal,
Y Toyoda, and I Miwa, and M Kamiya, and S Ogiso, and T Nonogaki, and S Aoki, and J Okuda
June 1963, Nature,
Copied contents to your clipboard!